Emergent BioSolutions (EBS)

Add to Watchlists
Create an Alert
21.80 -0.40  -1.80% NYSE Sep 19, 8:00PM BATS Real time Currency in USD
View Full Chart
EBS Price Chart
View All Events

EBS Events

Date Type Description
08/07/2014 17:00 EDT Misc Q2 2014 Emergent BioSolutions Inc. Earnings Conference Call
08/07/2014 Earnings Q2 2014 Emergent BioSolutions Inc. Earnings Results
05/22/2014 Misc Annual General Meeting for Emergent BioSolutions Inc
05/08/2014 17:00 EDT Misc Emergent BioSolutions Inc 1Q2014 Earning Conference Call
05/08/2014 Earnings Emergent BioSolutions Inc 1Q2014 Earning Result
03/06/2014 Earnings Emergent BioSolutions, Inc. Q4 2013 Earning Result
03/06/2014 Misc Emergent BioSolutions, Inc. Q4 2013 Earning Conference Call
01/13/2014 Misc Emergent Biosolutions Announces Preliminary 2013 Financial Results and Provides 2014 Forecast
12/11/2013 18:45 EST Misc Emergent Biosolutions Inc. Corporate Conference Call to Discuss the Proposed Acquisition of Cangene Corporation
11/07/2013 17:00 EDT Misc Emergent Biosolutions to Release Third Quarter 2013 Financial Results and Conduct a Conference Call on November 7, 2013
View All Performance Charts

EBS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Emergent BioSolutions is up 12.31% over the last year vs S&P 500 Total Return up 19.16%, Spectrum Pharmaceuticals down 3.90%, and Curis down 65.38%.

Get Quote for
Advertisement

Portfolio Strategies Featuring EBS

Did Emergent BioSolutions make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

EBS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.emergentbiosolutions.com
  • IR Website: http://investors.emergentbiosolutions.com/
  • HQ Country: United States
  • HQ State/Province: Maryland
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Emergent BioSolutions, Inc., is a biopharmaceutical company, which is engaged in the development, manufacture and commercialization of vaccine and immune-related therapeutic that assist the body’s immune system to prevent or treat disease.

EBS Excel Add-In Codes

  • Name: =YCI("EBS","name")
  • Description: =YCI("EBS","description")
  • Sector: =YCI("EBS","sector")
  • Industry: =YCI("EBS","industry")
  • Est. Current Fiscal Year End: =YCI("EBS","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.